ACHTUNG: Wartung im Hintergrund noch ca. 18 Minuten aktiv. Artikel, die zu Warenkorb/Merkliste hinzugefügt werden, sind erst nach Abschluss der Wartung sichtbar.
Merkliste
Die Merkliste ist leer.
Der Warenkorb ist leer.
Kostenloser Versand möglich
Kostenloser Versand möglich
Bitte warten - die Druckansicht der Seite wird vorbereitet.
Der Druckdialog öffnet sich, sobald die Seite vollständig geladen wurde.
Sollte die Druckvorschau unvollständig sein, bitte schliessen und "Erneut drucken" wählen.

Aggressive Lymphomas

BuchGebunden
EUR140,00

Produktbeschreibung

This book summarizes current knowledge of the biology and molecular pathogenesis of aggressive lymphomas and reviews the state of the art in diagnostic and therapeutic strategies. The aim is both to provide the reader with a sound understanding of the very significant progress that has been achieved in the understanding and management of these malignancies over recent years and to facilitate appropriate choice of the therapeutic strategy in individual cases. The assessment of different prognostic parameters are clearly presented in order to permits effective risk stratification that impacts on treatment choice. Recent insights into lymphomagenesis are exemplified and may assist in identifying emerging therapeutic targets. The comprehensive and up-to-date nature of the book will make it an ideal reference for all physicians and researchers interested in lymphoma, including clinicians from various medical specialties, biologists, pathologists, radiologists and nuclear medicine specialist, as well as students.
Weiterlesen

Details

ISBN/GTIN978-3-030-00361-6
ProduktartBuch
EinbandGebunden
VerlagSpringer
ErscheinungsortCham
ErscheinungslandSchweiz
Erscheinungsdatum15.01.2019
Auflage1st ed. 2019
Seiten360 Seiten
SpracheEnglisch
Illustrationen65 farbige Abbildungen, 5 s/w Abbildungen
Artikel-Nr.1355705
KatalogVLB
Datenquelle-Nr.30db394f7f1042f6bfe594b5e049c376
Weitere Details

Reihe

Bewertungen

Autor/in

Professor Georg Lenz is Director of the Department of Medicine A, Hematology, Oncology and Pneumology at the University Hospital in Münster, Germany. Before his move to Münster he previously worked at the Ludwig-Maximilians University Munich, the National Cancer Institute in Bethesda (USA), and the Charité - Universitätsmedizin Berlin. His basic and clinical research focuses on the molecular characterization of malignant lymphomas and the performance of clinical trials using specific therapeutics.

Professor Gilles Salles is Head of the Hematology Department in Lyon University Hospitals (Hospices Civils de Lyon & Université Claude Bernard Lyon-1) and co-director of the research team "Clinical and Experimental Models of Lymphoma" at the Cancer Research Center of Lyon (Institut National de la Santé et de la Recherche Médicale). He trained in Hematology and Immunology at the Université Claude Bernard in Lyon and at the Dana Farber Cancer Institue (Havard Medical Scholl, Boston, USA). He conducted several leading international clinical trials as well as translational studies in the field of lymphoma.

Schlagworte